Personal profile
Biography
Simon Wilkinson studied at University of Edinburgh from 1996, gaining a 1st class degree in Biochemistry. In late 2000, he moved to the Institute of Cancer Research in London, to study for his doctorate in the Cancer Research UK Tumour Cell Signalling Unit, under the supervision of Prof. Chris Marshall. His work here investigated the different signalling requirements of diverse tumour cell types for motility and invasion. In the course of this work he became very interested in the different mechanisms by which tumour cells engage protein kinase signalling pathways.
In 2005, Simon joined the Beatson Institute for Cancer Research as a postdoctoral scientist. Here, working with Prof. Kevin Ryan, he became interested in autophagy in cancer and worked on the identification of an ‘autophagy kinome’ - a set of protein kinases that engaged various different forms of autophagy. In 2010, Simon moved to Edinburgh to work with Prof. Margaret Frame looking at the interplay between autophagy and cell signalling, focussing on Src kinase. In 2012, he was awarded a prestigious Career Development Fellowship from Cancer Research UK in order to establish his own laboratory in Edinburgh. His lab now studies the interplay between intracellular membrane dynamics - particularly membrane modification by ubiquitin-like proteins and the autophagy pathway - and cell signalling during cancer development and treatment, focussing on processes such as control of gene expression, cellular dedifferentiation and therapy-induced senescence.
Research Interests
Autophagy is an evolutionarily-conserved mechanism by which cells remove old proteins and organelles by transporting them to the lysosome (in effect, a cellular garbage disposal facility). The autophagy pathway also acts as a hub for control of cell fate by degrading specific signalling and structural proteins of the cell. These actions are important for the progression of a number of cancers. We use protein-protein interaction screens, imaging techniques and transgenic models to unpick the molecular events set in train by autophagy within pre-cancerous and cancerous cells. Thusly we gain understanding of new cellular processes that could be targeted for future cancer therapies.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
CCPG1 Is a Non-canonical Autophagy Cargo Receptor Essential for ER-Phagy and Pancreatic ER Proteostasis
Smith, M. D., Harley, M. E., Kemp, A. J., Wills, J., Lee, M., Arends, M., von Kriegsheim, A., Behrends, C. & Wilkinson, S., 22 Jan 2018, In: Developmental Cell. 44, 2, p. P217-232.e11Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function
Sakamaki, J.-I., Wilkinson, S., Hahn, M., Tasdemir, N., O'Prey, J., Clark, W., Hedley, A., Nixon, C., Long, J. S., New, M., Van Acker, T., Tooze, S. A., Lowe, S. W., Dikic, I. & Ryan, K. M., 18 May 2017, In: Molecular Cell. 66, 4, p. 517-532.e9 25 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Autophagy acts through TRAF3 and RELB to regulate gene expression via antagonism of SMAD proteins
Newman, A. C., Kemp, A. J., Drabsch, Y., Behrends, C. & Wilkinson, S., 16 Nov 2017, In: Nature Communications. 8, 1537.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
ER homeostasis and autophagy
Smith, M. & Wilkinson, S., 12 Dec 2017, In: Essays in biochemistry.Research output: Contribution to journal › Review article › peer-review
Open AccessFile -
TBK1 Kinase Addiction in Lung Cancer Cells Is Mediated via Autophagy of Tax1bp1/Ndp52 and Non-Canonical NF-kappa B Signalling
Newman, A. C., Scholefield, C. L., Kemp, A. J., Newman, M., McIver, E. G., Kamal, A. & Wilkinson, S., 29 Nov 2012, In: PLoS ONE. 7, 11, p. e50672 12 p., ARTN e50672.Research output: Contribution to journal › Article › peer-review
Open AccessFile
-
FAM134 as an antimetastatic target in pancreatic cancer
Jimenez Moreno, N. (Principal Investigator) & Wilkinson, S. (Co-investigator)
1/09/25 → 28/02/27
Project: Research
-
Spatial proteomic discovery of biomarkers of malignant transformation in early pancreatic cancer
Wilkinson, S. (Principal Investigator) & Von Kriegsheim, A. (Co-investigator)
1/04/25 → 31/03/27
Project: Research
-
G9a Inhibition in Pancreatic Cancer
Wilkinson, S. (Principal Investigator) & Carragher, N. (Co-investigator)
Melville Trust for Care and Cure of Cancer
1/09/23 → 31/08/26
Project: Research
-
ER-phagy networks in cancer
Wilkinson, S. (Principal Investigator)
1/07/20 → 30/06/27
Project: Research
-
Determing the utility of the senescence associated secretory phenotype as a biomarker of preinvasive lung cancer
Millar, F. (Principal Investigator) & Wilkinson, S. (Co-investigator)
1/03/22 → 30/09/22
Project: Research
Press/Media
-
Dr Simon Wilkinson discusses future treatment of neurodegenerative diseases
3/10/16
3 items of Media coverage
Press/Media: Expert Comment
-
Cancer Research UK awards two Edinburgh University researchers
23/07/11
1 item of Media coverage
Press/Media: Research